Does agomelatine block 5-HT2C receptors in humans?

Saved in:
Bibliographic Details
Published inPsychopharmacology Vol. 213; no. 2-3; pp. 653 - 655
Main Authors Sharpley, Ann L., Rawlings, Nancy B., Brain, Susannah, McTavish, Sarah F. B., Cowen, Philip J.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.02.2011
Subjects
Acetamides - adverse effects
Acetamides - pharmacology
Adult
Biomedical and Life Sciences
Biomedicine
Cross-Over Studies
Double-Blind Method
Female
Humans
Hypnotics and Sedatives - adverse effects
Hypnotics and Sedatives - pharmacology
Letter to Editor
Male
Middle Aged
Neurosciences
Pharmacology/Toxicology
Polysomnography
Psychiatry
Receptor, Serotonin, 5-HT2C - drug effects
Receptor, Serotonin, 5-HT2C - metabolism
Sleep - drug effects
Young Adult
Mirtazapine
Melatonin
Agomelatine
Olanzapine
Slow Wave Sleep
Online AccessGet full text

Cover

Author Rawlings, Nancy B.
McTavish, Sarah F. B.
Cowen, Philip J.
Brain, Susannah
Sharpley, Ann L.
Author_xml – sequence: 1
  givenname: Ann L.
  surname: Sharpley
  fullname: Sharpley, Ann L.
  organization: University Department of Psychiatry
– sequence: 2
  givenname: Nancy B.
  surname: Rawlings
  fullname: Rawlings, Nancy B.
  organization: University Department of Psychiatry
– sequence: 3
  givenname: Susannah
  surname: Brain
  fullname: Brain, Susannah
  organization: University Department of Psychiatry
– sequence: 4
  givenname: Sarah F. B.
  surname: McTavish
  fullname: McTavish, Sarah F. B.
  organization: University Department of Psychiatry
– sequence: 5
  givenname: Philip J.
  surname: Cowen
  fullname: Cowen, Philip J.
  email: phil.cowen@psych.ox.ac.uk
  organization: University Department of Psychiatry
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20730417$$D View this record in MEDLINE/PubMed
BookMark eNp9j7lOAzEQhi0URA54ABq0L2AYH-u1K4SWI0iRaEJteR07JGTtyE4K3h5HC5RMMxr9x-ibolGIwSF0TeCWADR3GYAShoEAJkoxLM7QhHBGMYWGjtAEgDHMSC3HaJrzFspwyS_QuOgMOGkmiD5Glyuzjr3bmcMmuKrbRftZ1Xi-pG2VnHX7Q0y52oTq49ibkO8v0bk3u-yufvYMvT8_Lds5Xry9vLYPC2xpLUX5C94rIa3zwlHvBbGcW18b700naG06Q5gy0ilrayLsSjRSNU2jOkk5sR2bITL02hRzTs7rfdr0Jn1pAvrErwd-Dae78GtRMjdDZn_serf6S_wCFwMdDLlIYe2S3sZjCoXjn9Zvqadl7Q
CitedBy_id crossref_primary_10_1007_s00213_012_2656_6
crossref_primary_10_3390_ijms140612458
crossref_primary_10_1177_0269881115592341
crossref_primary_10_2165_11593960_000000000_00000
crossref_primary_10_1192_pb_bp_113_043505
crossref_primary_10_4137_CMPsy_S7989
crossref_primary_10_1007_s00213_016_4381_z
Cites_doi 10.1016/0028-3908(94)90077-9
10.1345/aph.1L296
10.1016/S0006-3223(99)00273-5
10.1016/0165-1781(91)90013-F
10.1007/BF02246354
10.1016/0006-3223(94)00135-P
10.1111/j.1365-2265.2005.02341.x
10.1177/026988118900300301
10.1124/jpet.103.051797
10.1093/sleep/25.6.666
ContentType Journal Article
Copyright Springer-Verlag 2010
Copyright_xml – notice: Springer-Verlag 2010
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1007/s00213-010-1993-6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-2072
EndPage 655
ExternalDocumentID 10_1007_s00213_010_1993_6
20730417
Genre Letter
Controlled Clinical Trial
GroupedDBID -4W
-BR
.55
3SX
40D
40E
95.
95~
ABMNI
AGWIL
ALMA_UNASSIGNED_HOLDINGS
KOW
N2Q
R9-
RHV
SBY
SOJ
X7M
~EX
---
-56
-5G
-EM
-Y2
-~C
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
123
199
1N0
1SB
2.D
203
28-
29P
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2QV
2VQ
2~H
30V
36B
3O-
3V.
4.4
406
408
409
53G
5QI
5RE
5VS
67N
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
96X
AAAVM
AABHQ
AACDK
AAEOY
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAQLM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABIVO
ABJNI
ABJOX
ABKCH
ABKTR
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTAH
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACNCT
ACOKC
ACOMO
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
B0M
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BMSDO
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CS3
CSCUP
CUY
CVF
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
DXH
EAD
EAP
EBC
EBD
EBLON
EBS
ECM
EIF
EIHBH
EIOEI
EJD
EMB
EMK
EMOBN
EN4
EPAXT
EPL
EPS
ESBYG
ESX
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
ICJ
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
INR
IPY
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M1P
M2M
M4Y
MA-
MK0
N9A
NAPCQ
NB0
NDZJH
NPM
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
PF-
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TN5
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UAP
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WIP
WJK
WK6
WK8
WOW
XOL
YLTOR
YQJ
YYP
Z45
Z7U
Z7W
Z82
Z83
Z87
Z8O
Z8Q
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZY4
~8M
AAYXX
CITATION
ID FETCH-LOGICAL-c2586-310ff968cef6e2ff61c44cf5affab625aba139a8e9cc516cd67897779b8241cb3
IEDL.DBID U2A
ISSN 0033-3158
IngestDate Fri Aug 23 01:56:03 EDT 2024
Wed Oct 16 00:41:51 EDT 2024
Wed Oct 12 10:50:06 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 2-3
Keywords Mirtazapine
Melatonin
Agomelatine
Olanzapine
Slow Wave Sleep
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2586-310ff968cef6e2ff61c44cf5affab625aba139a8e9cc516cd67897779b8241cb3
PMID 20730417
PageCount 3
ParticipantIDs crossref_primary_10_1007_s00213_010_1993_6
pubmed_primary_20730417
springer_journals_10_1007_s00213_010_1993_6
PublicationCentury 2000
PublicationDate 2011-02-00
PublicationDateYYYYMMDD 2011-02-01
PublicationDate_xml – month: 02
  year: 2011
  text: 2011-02-00
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
PublicationTitle Psychopharmacology
PublicationTitleAbbrev Psychopharmacology
PublicationTitleAlternate Psychopharmacology (Berl)
PublicationYear 2011
Publisher Springer-Verlag
Publisher_xml – name: Springer-Verlag
References Leproult, Van Onderbergen, L’Hermite-Balériaux, Van Cauter, Copinschi (CR4) 2005; 63
Dolder, Nelson, Snider (CR3) 2008; 42
Aslan, Isik, Cosar (CR2) 2002; 25
Seibyl, Krystal, Price, Woods, D’Amico, Heninger, Charney (CR7) 1991; 38
Sharpley, Vassallo, Cowen (CR10) 2000; 47
Sharpley, Cowen (CR8) 1995; 37
Quera Salva, Vanier, Laredo, Hartley, Chapotot, Moulin, Lofaso, Guilleminault (CR6) 2007; 10
Attenburrow, Cowen, Sharpley (CR1) 1996; 126
Millan, Gobert, Lejeune, Dekeyne, Newman-Tancredi, Pasteau, Rivet, Cussac (CR5) 2003; 306
Solomon, Sharpley, Cowen (CR11) 1989; 3
Sharpley, Elliott, Attenburrow, Cowen (CR9) 1994; 33
22349274 - Psychopharmacology (Berl). 2012 May;221(1):177-8; author reply 179
AL Sharpley (1993_CR10) 2000; 47
R Leproult (1993_CR4) 2005; 63
MEJ Attenburrow (1993_CR1) 1996; 126
JP Seibyl (1993_CR7) 1991; 38
AL Sharpley (1993_CR8) 1995; 37
MJ Millan (1993_CR5) 2003; 306
RA Solomon (1993_CR11) 1989; 3
CR Dolder (1993_CR3) 2008; 42
S Aslan (1993_CR2) 2002; 25
M-A Quera Salva (1993_CR6) 2007; 10
AL Sharpley (1993_CR9) 1994; 33
References_xml – volume: 33
  start-page: 467
  year: 1994
  end-page: 471
  ident: CR9
  article-title: Slow wave sleep in humans: Role of 5-HT and 5-HT receptors
  publication-title: Neuropharmacology
  doi: 10.1016/0028-3908(94)90077-9
  contributor:
    fullname: Cowen
– volume: 42
  start-page: 1822
  year: 2008
  end-page: 31
  ident: CR3
  article-title: Agomelatine treatment of major depressive disorder
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1L296
  contributor:
    fullname: Snider
– volume: 25
  start-page: 677
  year: 2002
  end-page: 9
  ident: CR2
  article-title: The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers
  publication-title: Sleep
  contributor:
    fullname: Cosar
– volume: 47
  start-page: 468
  year: 2000
  end-page: 470
  ident: CR10
  article-title: Olanzapine increases slow wave sleep: evidence for blockade of central 5-HT receptors in vivo
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00273-5
  contributor:
    fullname: Cowen
– volume: 38
  start-page: 227
  year: 1991
  end-page: 236
  ident: CR7
  article-title: Effects of ritanserin on the behavioral, neuroendocrine and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects
  publication-title: Psychiat Res
  doi: 10.1016/0165-1781(91)90013-F
  contributor:
    fullname: Charney
– volume: 126
  start-page: 179
  year: 1996
  end-page: 181
  ident: CR1
  article-title: Low dose melatonin improves sleep in healthy middle-aged subjects
  publication-title: Psychopharmacol
  doi: 10.1007/BF02246354
  contributor:
    fullname: Sharpley
– volume: 37
  start-page: 85
  year: 1995
  end-page: 98
  ident: CR8
  article-title: Effect of pharmacologic treatments on the sleep of depressed patients
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(94)00135-P
  contributor:
    fullname: Cowen
– volume: 63
  start-page: 298
  year: 2005
  end-page: 304
  ident: CR4
  article-title: Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2005.02341.x
  contributor:
    fullname: Copinschi
– volume: 10
  start-page: 691
  year: 2007
  end-page: 696
  ident: CR6
  article-title: Major depressive disorder, sleep EEG and agomelatine: an open label study
  publication-title: Int J Neuropsychopharmacol
  contributor:
    fullname: Guilleminault
– volume: 3
  start-page: 125
  year: 1989
  end-page: 129
  ident: CR11
  article-title: Increased slow wave sleep with 5-HT receptor antagonists: detection by ambulatory EEG recording and automatic sleep stage analysis.
  publication-title: J Psychopharmacol
  doi: 10.1177/026988118900300301
  contributor:
    fullname: Cowen
– volume: 306
  start-page: 954
  year: 2003
  end-page: 964
  ident: CR5
  article-title: The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytptamine receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.103.051797
  contributor:
    fullname: Cussac
– volume: 306
  start-page: 954
  year: 2003
  ident: 1993_CR5
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.103.051797
  contributor:
    fullname: MJ Millan
– volume: 33
  start-page: 467
  year: 1994
  ident: 1993_CR9
  publication-title: Neuropharmacology
  doi: 10.1016/0028-3908(94)90077-9
  contributor:
    fullname: AL Sharpley
– volume: 63
  start-page: 298
  year: 2005
  ident: 1993_CR4
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2005.02341.x
  contributor:
    fullname: R Leproult
– volume: 10
  start-page: 691
  year: 2007
  ident: 1993_CR6
  publication-title: Int J Neuropsychopharmacol
  contributor:
    fullname: M-A Quera Salva
– volume: 42
  start-page: 1822
  year: 2008
  ident: 1993_CR3
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1L296
  contributor:
    fullname: CR Dolder
– volume: 38
  start-page: 227
  year: 1991
  ident: 1993_CR7
  publication-title: Psychiat Res
  doi: 10.1016/0165-1781(91)90013-F
  contributor:
    fullname: JP Seibyl
– volume: 3
  start-page: 125
  year: 1989
  ident: 1993_CR11
  publication-title: J Psychopharmacol
  doi: 10.1177/026988118900300301
  contributor:
    fullname: RA Solomon
– volume: 25
  start-page: 677
  year: 2002
  ident: 1993_CR2
  publication-title: Sleep
  doi: 10.1093/sleep/25.6.666
  contributor:
    fullname: S Aslan
– volume: 37
  start-page: 85
  year: 1995
  ident: 1993_CR8
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(94)00135-P
  contributor:
    fullname: AL Sharpley
– volume: 126
  start-page: 179
  year: 1996
  ident: 1993_CR1
  publication-title: Psychopharmacol
  doi: 10.1007/BF02246354
  contributor:
    fullname: MEJ Attenburrow
– volume: 47
  start-page: 468
  year: 2000
  ident: 1993_CR10
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00273-5
  contributor:
    fullname: AL Sharpley
SSID ssj0000484
ssj0068394
Score 2.083038
SourceID crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 653
SubjectTerms Acetamides - adverse effects
Acetamides - pharmacology
Adult
Biomedical and Life Sciences
Biomedicine
Cross-Over Studies
Double-Blind Method
Female
Humans
Hypnotics and Sedatives - adverse effects
Hypnotics and Sedatives - pharmacology
Letter to Editor
Male
Middle Aged
Neurosciences
Pharmacology/Toxicology
Polysomnography
Psychiatry
Receptor, Serotonin, 5-HT2C - drug effects
Receptor, Serotonin, 5-HT2C - metabolism
Sleep - drug effects
Young Adult
Title Does agomelatine block 5-HT2C receptors in humans?
URI https://link.springer.com/article/10.1007/s00213-010-1993-6
https://www.ncbi.nlm.nih.gov/pubmed/20730417
Volume 213
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NT8IwFH9BSIwXo_iFH6QHw0GpGaXrtpMBBIkGwgESPC1d1xpDHMThgf_edl9EowdPS5Om2V6393vr-73fA7i23bYwSIM1-ApMOeXYs6XCnlSMSENnTLoojMZsOKNPc3teAlIcXUSLuzwjmTjqotbNoJGh_lg44ZyxHajo2IEaGteMdLbel5rCy3TA9A2kMsxtU0Rmu3la87f1vgFTgUY_0qMJ6gwOYD8LF1En3d9DKMmoCrujLCFehcYklZ7eNNF0W0kVN1EDTbai1JsjIA9LGSP-unxP2G-RRIGGsQWy8XBKekj7PbkyjXfQW4SSvn3x_THMBv1pb4izfglYENtl-gktpTzmCm1nSZRiLUGpUDZXigf6P4cHXMd73JWeEHaLiVADlQ7_HC9wNY6LoH0C5WgZyTNATuCEbkj1FEmoQ4yEN2M85IrK0OXMqsFNbix_lcpi-IUAcmJZ3zJjbVmf1eA0NWcxlRjHQltODW5z-_rZtxP_vc75v2ZfwF56_muoJ5dQXn98yisdQKyDOlQ6g253bK6PL8_9evIGfQGHPrur
link.rule.ids 315,783,787,27938,27939,41095,41537,42164,42606,52125,52248
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV07T8MwED5BkYAFQXmVpwfUAYiUuo7jTKgqVAHaqkMrdYscx0YIkVakDP332M6jAsHAaOlkJRfnvkvuu-8ArjzWFgZpHA2-wiGccCfwpHICqSiWhs5opygMhjSckKepNy36uLOS7V6WJG2krprdDBwZ7o_rWNIZXYcNI69ujvUEd1bhl5jOy3xB9RXkOsxt00XmsbKu-dt-35CpgqMf9VELO71d2CnyRdTJH_AerMm0DpuDoiJeh-Yo155e3qLxqpUqu0VNNFqpUi_3Ad_PZIb4y-zd0t9SiWKNY2_Ic8Ix7iId-OTcTN5Brymyg_uyuwOY9B7G3dApBiY4AnuM6jt0lQooE9rREitFW4IQoTyuFI_1hw6PuU74OJOBEF6LikQjlc7__CBmGshF3D6EWjpL5TEgP_YTlhBtIjHxsdHwppQnXBGZME7dBlyXzormuS5GVCkgW89Grllrz0a0AUe5OytTbCILafkNuCn9GxUvT_b3Pif_sr6ErXA86Ef9x-HzKWznP4MND-UMaouPT3mus4lFfGFPzxfTubv2
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwED5BkSoWHuVVnh5QByAlSR0nmRAqlEIp6tBKZQqOYyOESCuSDuXXY8dJKxAMiNGSZTln575L7rvvAI4dr8EU0hgSfJmBKaaG73Bh-FwQmys6Y9ZFoftA2gN8N3SGeZ_TpGC7FylJXdOgVJri9HwcifNZ4ZuCJsUDMo2MgEYWYQlbMloowdLlzWPneu6MsarD1AMi96NVmRuqpszxiiznTyt-wakZOH3LlmYg1FqFp2L7mnvyWp-kYZ19fFN2_MfzrcFKHqCiS32j1mGBxxUod_MUfAVqPS12PT1D_XntVnKGaqg3l8GeboB9NeIJos-jt4xvF3MUSuB8RY7R7ttNJD0tH6tWP-glRlmnwORiEwat636zbeQdGgxmOx6RRjSF8InH5MlyWwhiMYyZcKgQNJRfVjSkMsKkHvcZcyzCIgmNMuB0_dCTkQMLG1tQikcx3wHkhm7kRVhO4TZ2bSUaTgiNqMA88igxq3BSnEcw1kIcwUxyOTNXYKqxNFdAqrCtT2w21VauDFtuFU4L6wf525r8vs7un2YfQbl31Qrubx86e7Csfz4r3ss-lNL3CT-Q0UsaHuY39BOi3uGU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Does+agomelatine+block+5-HT2C+receptors+in+humans%3F&rft.jtitle=Psychopharmacology&rft.au=Sharpley%2C+Ann+L.&rft.au=Rawlings%2C+Nancy+B.&rft.au=Brain%2C+Susannah&rft.au=McTavish%2C+Sarah+F.+B.&rft.date=2011-02-01&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=213&rft.issue=2-3&rft.spage=653&rft.epage=655&rft_id=info:doi/10.1007%2Fs00213-010-1993-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00213_010_1993_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon